- CIIX
reported $1,444,822 in revenues for the third quarter of fiscal 2019,
marking an 81 percent increase from the same quarter of the previous year
- The
company’s hemp and CBD consumer product sales grew to $1,061,318 in the
third quarter of fiscal 2019
- CIIX
CEO projects a “fruitful” performance in the coming year
ChineseInvestors.com Inc. (OTCQB: CIIX) reported sharp
sales gains for the three months ended February 28, 2019. The quarterly gains
reached 81 percent, totaling $1,444,822, as compared to $796,304 for the
previous year. CIIX CEO Warren Wang attributed a large part of the impressive
growth to a major increase in industrial hemp and CBD product sales during the
period; sales for that segment reached $1,061,318 in the third quarter of
fiscal 2019, marking a huge jump from $183,185 during the same period of the
previous year (http://ibn.fm/8USk8).
That wasn’t the only good news for CIIX. Subscription
revenues for the company also rose by six percent for the quarter, landing at
$229,220, as compared to $214,506 in the previous year during the same period.
“This has been an extremely eventful quarter for us,
demonstrated by the successful product launches and initiatives that we have
taken to consolidate branding and provide ease and accessibility for our
consumers,” Wang said in a news release. “Our financial performance and highlights
for the quarter are a testament to the popularity and demand for our CBD and
hemp products.”
Wang added that CIIX has become a “key player in the Chinese
markets” and expressed confidence that the year ahead will be a “fruitful” one
for the company.
CIIX is a diverse company that offers its audience of
Chinese-speaking investors real-time market commentary, analysis and
education-related services in Chinese language sets. During the quarter ended
February 28, 2019, CIIX rebranded its consumer products line under the ‘opt’
brand and consolidated its e-commerce sites to offer a one-stop shopping
experience on its website (http://ibn.fm/p8rmE).
Recognizing the opportunities in the U.S. cannabis industry, CIIX is laying the
groundwork to capitalize on growing demand for cannabidiol-based nutrition and
health products.
For more information, visit the company’s website at www.ChineseInvestors.com
NOTE TO INVESTORS: The latest news and updates
relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment